Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Payables: 2023-2024

Historic Payables for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $17.1 million.

  • Zenas BioPharma's Payables fell 57.27% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.5 million, marking a year-over-year change of. This contributed to the annual value of $17.1 million for FY2024, which is 217.57% up from last year.
  • Zenas BioPharma's Payables amounted to $17.1 million in FY2024, which was up 217.57% from $5.4 million recorded in FY2023.
  • Zenas BioPharma's 5-year Payables high stood at $17.1 million for FY2024, and its period low was $5.4 million during FY2023.
  • In the last 2 years, Zenas BioPharma's Payables had a median value of $11.3 million in 2023 and averaged $11.3 million.
  • Data for Zenas BioPharma's Payables shows a peak YoY skyrocketed of 217.57% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Payables stood at $5.4 million in 2023, then soared by 217.57% to $17.1 million in 2024.